TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ) is now available.
Hansoh Pharmaceutical Group Company Limited announced an interim dividend of HKD 0.2316 per share for the six months ending June 30, 2025. The dividend will be paid on October 30, 2025, and reflects the company’s strong financial performance and commitment to delivering value to its shareholders. This announcement may positively impact the company’s market position and investor confidence.
The most recent analyst rating on (HK:3692) stock is a Buy with a HK$34.83 price target. To see the full list of analyst forecasts on Hansoh Pharmaceutical Group Company Limited stock, see the HK:3692 Stock Forecast page.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited operates in the pharmaceutical industry, focusing on the development, production, and sale of innovative and high-quality medicines. The company is known for its commitment to addressing critical healthcare needs and enhancing patient outcomes.
Average Trading Volume: 11,591,839
Technical Sentiment Signal: Buy
Current Market Cap: HK$221.8B
See more insights into 3692 stock on TipRanks’ Stock Analysis page.